RECRUITING

Efficacy of Point Of Service Testing in MBC

Talk to us

Conditions

Metastatic CancerBreast Cancergenetic counseling

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will assess the efficacy of an innovative point of service cancer genetics counseling delivery model for metastatic breast cancer (MBC) patients whom have received a referral for hereditary cancer genetic counseling and testing.

Official Title

Efficacy of Point Of Service Testing in Metastatic Breast Cancer

Quick Facts

Study Start:2019-06-11
Study Completion:2025-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03983577

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Ability of participant OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent.
  2. * Able to speak and read in the English language.
  3. * Have a diagnosis of human epidermal growth factor receptor 2 (HER2) negative metastatic breast cancer.
  4. * Participants must be enrolled in the parent registry study.
  1. * Genetic testing for a breast cancer gene (BRCA) BRCA1 and BRCA2 mutation completed after 2013 or any BRCA 1 and BRCA2 testing with large rearrangement testing. Prior genetic counseling is allowed.
  2. * Psychiatric illness/social situations that would limit compliance with study requirements.

Contacts and Locations

Study Contact

CT Nurse Navigator
CONTACT
913-945-7552
ctnursenav@kumc.edu

Principal Investigator

Lauren Nye, MD
PRINCIPAL_INVESTIGATOR
University of Kansas

Study Locations (Sites)

The University of Kansas Cancer Center, Westwood Campus
Kansas City, Kansas, 66205
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

  • Lauren Nye, MD, PRINCIPAL_INVESTIGATOR, University of Kansas

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-06-11
Study Completion Date2025-08

Study Record Updates

Study Start Date2019-06-11
Study Completion Date2025-08

Terms related to this study

Keywords Provided by Researchers

  • genetic counseling

Additional Relevant MeSH Terms

  • Metastatic Cancer
  • Breast Cancer